학술논문

PP153 Efficacy And Safety of Onasemnogene Abeparvovec For The Treatment Of Patients With Spinal Muscular Atrophy Type 1: Meta-Analysis.
Document Type
Abstract
Source
International Journal of Technology Assessment in Health Care; 2023 Supplement 1, Vol. 39, pS93-S93, 1p
Subject
Language
ISSN
02664623
Abstract
Copyright of International Journal of Technology Assessment in Health Care is the property of Cambridge University Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)